June 6, 2023 News by Marisa Wexler, MS Novel immune cell strategy found to reverse disease in MS mice Microparticles that activate regulatory T-cells, or Tregs, an immune cell type with anti-inflammatory properties, reversed the accumulation of physical disability due to multiple sclerosis (MS) in a mouse model of the neurodegenerative disorder, a new study shows. Use of the novel strategy even cured some of the animals. “We…
January 31, 2022 News by Marta Figueiredo, PhD Higher Risk of Long COVID Possible With MS, UK Study Suggests Nearly a third of multiple sclerosis (MS)Ā patients with COVID-19 experience symptoms that last at least one month, according to a review of of more than 550 infected MS patients in the U.K. who did not need to be hospitalized. This study’s rate is higher than that reported for the…
October 1, 2020 News by Joana Carvalho, PhD #MSVirtual2020 – Disability Level and DMT Use Don’t Raise COVID-19 Risk, UK Study Finds When safety measures like isolation are in place, neither disease-modifying therapy (DMT) use nor greater physical disability appear to heighten the risk of people with multiple sclerosis (MS) contracting COVID-19, a large U.K. registry-based study found. Preliminary study data also suggested that these factors do not affect…
July 9, 2018 News by Jose Marques Lopes, PhD #EAN2018 – Spinal Cord Atrophy Better Marker of Physical Disability in SPMS Than Brain Volume Loss, Study Reports Atrophy seen in areas of the spinal cord is a better predictor of physical disability in secondary progressive multiple sclerosis (SPMS) patients than loss of brain volume, a new study reports. The research was presented at theĀ 4th Congress of the European Academy of NeurologyĀ (EAN), recently held in Lisbon,…
August 1, 2017 News by Jose Marques Lopes, PhD Long-term Tysabri Treatment Improved Quality of Life and Satisfaction with Therapy in Relapsing MS Patients, Study Finds Long-term Tysabri (natalizumab) treatment of relapsing multiple sclerosis (RMS) improves physical and mental health and leads to greater satisfaction with therapy, new research shows. The study, āLong-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis,ā appeared in the journal…
June 22, 2016 News by Patricia Silva, PhD Poor Physical and Cognitive Skills in MS Patients Linked to Cerebral Microbleeds As we age, the risk that small blood vessels will start leaking into brain tissue increases, raising ourĀ risk ofĀ dementia, stroke, and Parkinsonās disease. New research reveals that peopleĀ with multiple sclerosis (MS) also have these so-called cerebral microbleeds, andĀ links them to increasedĀ physical and cognitive disability. When Robert Zivadinov, a professor of…
January 14, 2016 News by Patricia Silva, PhD Young MS Patients Gain in Functional Connectivity with Onset of Damage to Brain A Canadian study showed that child-onset multiple sclerosis (MS) is characterized by increased functional connectivity withinĀ the brain, most likely a compensatory effect to preserve function and protect againstĀ physical disability. The study, titledĀ “Alterations in Functional and Structural Connectivity in Pediatric-Onset Multiple Sclerosis,“Ā was published in the journalĀ …